Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy
Edward H. Schuchman, María Dolores Ledesma, Calogera M. Simonaro
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
Annelieke R. Müller, Bibiche den Hollander, Peter M. van de Ven, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Quality of Life and a Surveillant Endocannabinoid System
Ricardo Augusto de Melo Reis, Alinny Rosendo Isaac, Hércules Rezende Freitas, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 32
The Impact of Sphingomyelin on the Pathophysiology and Treatment Response to Olipudase Alfa in Acid Sphingomyelinase Deficiency
Monica Kumar, Mario Aguiar, Andreas Jessel, et al.
Genetics in Medicine Open (2024) Vol. 2, pp. 101888-101888
Open Access | Times Cited: 3
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Nuria Gómez-Cebrián, Elena Gras‐Colomer, José Luís Poveda Andrés, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1159-1159
Open Access | Times Cited: 4
Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage Diseases
Ana C. Puhl, Sean Ekins
GEN Biotechnology (2022) Vol. 1, Iss. 2, pp. 156-162
Open Access | Times Cited: 3
An update on multiplexed mass spectrometry‐based lysosomal storage disease diagnosis
Laura Darie‐Ion, Brînduşa Alina Petre
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 5, pp. 1135-1149
Closed Access | Times Cited: 1
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders
Calogera M. Simonaro, Makiko Yasuda, Edward H. Schuchman
Journal of Inherited Metabolic Disease (2024)
Open Access
Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis
Gerda Cristal Villalba Silva, Thiago Steindorff, Roselena Silvestri Schuh, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2085-2085
Open Access | Times Cited: 1
LSDDB: Lysosomal Storage Disorder Database for Lysosomal Proteins and Their Single Amino-Acid Substitutions
D. Meshach Paul, G. Chandrasekhar, E. Srinivasan, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 22, Iss. 05, pp. 589-603
Closed Access
Page 1

Scroll to top